Medicare will cover breakthrough Alzheimer’s drug Aduhelm only for participants in clinical trials, says the final national coverage determination—an “enormous setback for Alzheimer’s patients […]
CMS restricts coverage of Alzheimer’s drug to patients in clinical trials Read More »
The prognosis for the world on World Health Day is concerning. We are still battling a pandemic, and rising numbers in diseases like cancer,
World Health Day focuses on how the planet’s health impacts ours Read More »
Reauthorization of FDA user fee agreements will strengthen dialogue and advance innovation, Biotechnology Innovation Organization (BIO) Chief Scientific Officer Dr. Cartier Esham told the
BIO’s CSO tells Senate PDUFA is ‘critical to advancing innovation’ Read More »
Legislation to modernize the clinical drug development paradigm should be patient-centric, effective and inclusive, Biotechnology Innovation Organization (BIO) Chief Scientific Officer Dr. Cartier Esham
BIO’s CSO testifies at congressional hearing on PDUFA riders Read More »
The United States, European Union, India, and South Africa “reached a consensus on key elements of a long-sought intellectual property waiver for COVID-19 vaccines,”
Agreement reported on waiver of COVID vaccine IP protections Read More »
Phyllis Arthur, Vice President of Infectious Diseases & Emerging Science at the Biotechnology Innovation Organization (BIO), published an op-ed about the PREVENT Pandemics Act
BIO VP: PREVENT Pandemics Act a great step forward – but not the finish line Read More »
An opinion piece in the San-Jose Mercury News argues against forcing drug makers to allow for generic versions of their products simply because their
Other Voices: ‘Don’t sacrifice the miracle of American innovation’ Read More »
Russia’s decision to wage war on Ukraine brought home in very dramatic terms the urgency of weaning ourselves from fossil fuels, and creating more
War brings home urgency of alternative fuels, food stability Read More »
The Food and Drug Administration (FDA) on Friday announced approval of using nivolumab in certain procedures for treating non-small cell lung cancer (NSCLC), the
FDA approves Opdivo alongside chemo for the most common lung cancer Read More »
Gene editing can improve the health and welfare of animals, and the sustainability of our food supply, Elena Rice, CSO of Genus PLC told
USDA Forum told of gene editing benefits for animals and people Read More »
